During the second wave many people had find it difficult to book slot for RT-PCR test and many people get report after 7 to 9 days which led fatalities and delay in treatment. Now Pune-based Mylab Discovery Solutions set to launch India's first self-use rapid antigen test (RAT) kit for Covid-19 for Rs. 250 per pack. The product has been cleared by Indian Council of Medical Research (ICMR) on Wednesday. The test is developed in India and is named as CoviSelf.
The test results will then have to be uploaded by the users themselves through an app that is available on Google play store and Apple store. The data in the app of the mobile phone will be centrally stored in a secure server which is connected with the ICMR COVID-19 testing portal, where all data will be eventually stored.
The self-use test can be used by symptomatic individuals and immediate contacts of confirmed cases as per ICMR guidelines without the need for sample collection by a healthcare professional. The test kits can also be purchased without a prescription from local pharmacies and online channel partners.
The ICMR advisory says that all individuals who test positive may be considered as true positives and no repeat testing is required. However, all RAT negative symptomatic individuals will be treated as suspect Covid-19 cases and are advised to follow the ICMR/ Health ministry’s guidelines of home isolation protocol while awaiting the RTPCR test result. It also warns against indiscriminate testing.
The company will start shipping out test kit within a few days. Mylab current production capacity is 70 lakh tests per week and plans to increase its capacity to 1 crore tests per week within 14 days.
Mylab had also launched India's first locally developed RTPCR test a year ago.